Robotic Knee Replacement Market Report 2026

The robotic knee replacement market size has grown rapidly in recent years. It will grow from $2.77 billion in 2025 to $3.12 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis and joint disorders, increasing aging population globally, growing demand for advanced orthopedic surgical procedures, expansion of healthcare infrastructure and specialty orthopedic centres, advancements in robotic-assisted surgical technologies.

The robotic knee replacement market size is expected to see rapid growth in the next few years. It will grow to $5.02 billion by 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing integration of AI-enabled surgical planning systems, growing investments in robotic orthopedic surgery platforms, rising adoption of personalized and precision-based implant solutions, expansion of outpatient robotic surgery centres, increasing demand for enhanced surgical accuracy and reduced hospital stay durations. Major trends in the forecast period include increasing adoption of minimally invasive robotic knee replacement procedures, growing demand for patient-specific implant alignment and surgical planning, rising preference for faster recovery and reduced post-operative complications, expanding use of real-time intraoperative guidance systems in orthopedic surgeries, increasing focus on precision-based knee arthroplasty procedures for improved implant longevity.

The increasing number of total knee arthroplasty (TKA) procedures is expected to propel the growth of the robotic knee replacement market going forward. Total knee arthroplasty refers to a surgical procedure in which a damaged or diseased knee joint is replaced with an artificial implant to restore mobility and reduce pain, commonly performed in patients suffering from advanced osteoarthritis or degenerative knee disorders. The number of TKA procedures is increasing due to the rising prevalence of osteoarthritis and the growing demand for enhanced mobility and improved quality of life among the elderly population. Robotic knee replacement systems improve surgical accuracy, provide superior implant alignment, and enhance patient outcomes, thereby supporting the growing volume of procedures. For instance, in November 2025, according to the National Institutes of Health, a US-based government medical research agency, the total annual utilization of primary total knee arthroplasty (TKA) procedures in the United States is projected to increase substantially, growing by 110% by 2025, 182% by 2030, and 401% by 2040, indicating strong long-term demand growth. Therefore, the increasing number of total knee arthroplasty procedures is driving growth in the robotic knee replacement market.

Leading companies operating in the robotic knee replacement market are concentrating on developing innovative robotic surgical systems, such as handheld robotic power systems, to improve surgical precision and workflow efficiency. Handheld robotic power systems are portable, surgeon-operated devices that integrate powered surgical instruments with robotic guidance, sensors, and real-time feedback to improve accuracy and control during procedures such as bone cutting or implant placement. For instance, in February 2026, Stryker introduced the Mako RPS (Robotic Power System) for Total Knee, a handheld robotic platform that provides intuitive intraoperative planning, robotically enabled saw guidance responsive to the surgeon’s hand movements, and compatibility with the Triathlon Total Knee System to support consistent joint alignment while maintaining familiar surgical workflows. Although these technologies require investment in training and integration, they improve procedural precision, support predictable outcomes, and enhance surgeon confidence in robotic knee replacement procedures.

In July 2025, Zimmer Biomet Holdings Inc. acquired Monogram Technologies Inc. for $177 million. This acquisition supports Zimmer Biomet’s strategic objective of strengthening its robotic-assisted surgery portfolio and advancing autonomous orthopedic procedures through the integration of AI-driven and semi-autonomous robotic technologies. Monogram Technologies Inc. is a US-based company specializing in robotic systems for total knee arthroplasty, including semi-autonomous and fully autonomous surgical solutions.

Major companies operating in the robotic knee replacement market are Johnson & Johnson, Stryker Corporation, Smith & Nephew plc, Zimmer Biomet Holdings Inc., Penn Medicine, Intuitive Surgical Inc., Meril Life Sciences Pvt. Ltd., Renishaw plc, Medacta International SA, MicroPort Scientific Corporation, Corin Group plc, ConforMIS Inc., SUM Ultimate Medicare, THINK Surgical Inc., Curexo Inc., OMNIlife Science Inc., Monogram Technologies Inc., Kinomatic Ltd., Just Medical Inc., Orthokey Italia S. r. l.

North America was the largest region in the robotic knee replacement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic knee replacement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the robotic knee replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The robotic knee replacement market consists of revenues earned by entities by providing services such as robotic-assisted surgical procedures, preoperative planning using advanced imaging, intraoperative navigation and precision guidance, post-surgical monitoring, and maintenance and support of robotic surgical systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic knee replacement market also includes sales of robotic surgical systems, knee replacement implants, and precision instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.